Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|July 29, 2005
Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agentsTatiana Bogdanovich, Duygu Esel, Linda M Kelly, et al.
Journal of Clinical Microbiology|August 31, 2002
Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzaeMichael R Jacobs, Saralee Bajaksouzian, Anne Windau, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agentsKlaudia Kosowska-Shick, Kim Credito, Glenn A Pankuch, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
In vitro activity of the new quinolone WCK 771 against staphylococciMichael R Jacobs, Saralee Bajaksouzian, Anne Windau, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection modelsMahesh V Patel, Noel J De Souza, Shrikant V Gupte, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Incidence, epidemiology, and characteristics of quinolone-nonsusceptible Streptococcus pneumoniae in CroatiaGlenn A Pankuch, Bülent Bozdogan, Kensuke Nagai, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugsCatherine Clark, Lois M Ednie, Gengrong Lin, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Vancomycin-resistant Staphylococcus aureus isolate from a patient in PennsylvaniaFred C Tenover, Linda M Weigel, Peter C Appelbaum, et al.
Journal of Medicinal Chemistry|August 20, 2004
DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureusWenhao Hu, Roland W Bürli, Jacob A Kaizerman, et al.
Pageof 14